SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
Filing Date
Jun 19, 2018
Document Date
Jun 15, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC
Filer
Young Matthew P.